International Journal of Ophthalmology & Visual Science

| Peer-Reviewed |

Changes in Peripapillar Retinal Nerve Fiber Layer Analized by Td-Oct in Patients with Diabetic Retinopathy That Receive Panretinal Photocoagulation

Received: 14 October 2017    Accepted: 26 October 2017    Published: 05 December 2017
Views:       Downloads:

Share This Article

Abstract

In this study, changes in Retinal Nerve Fiber Layer (RNFL) within peripapillar zone in patients with diabetic retinopathy that accomplish criteria to receive panretinal photocoagulation are analyzed by TD-OCT (Time Domain-Optic Coherence Tomography) unit. This analysis was transversal retrospective and observational and was done in 46 eyes from 33 patients. According to laser application technique, time since application and day of the study, 4 groups of patients were set: the first with patients with less than 30 days since last laser application and day of study. The second with patients with 180 days since laser photocoagulation; the last two groups received panretinal photocoagulation plus macular selective laser with a TD-OCT performed 30 days (for the third group) and 180 days (the fourth group) after administration of treatment. The clinically significant finding was in comparing the group that received panretinal photocoagulation with TD-OCT after 30 days, and the group that received panretinal photocoagulation and TD-OCT after 180 days. Average thickness was less in the second group, with a statistical significant finding p=0.012 in inferior quadrant. Administer laser photocoagulation makes changes in the structure and function of the retina, and according to references many different results may be possible taking in count the equipment used to apply treatment and to take measurements. The patient must be informed about secondary and adverse effects after the treatment

DOI 10.11648/j.ijovs.20180301.11
Published in International Journal of Ophthalmology & Visual Science (Volume 3, Issue 1, March 2018)
Page(s) 1-6
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Diabetic Retinopathy, Panretinal Photocoagulation, Macular Laser, Time-Domain Optic Coherence Tomography, Retnal Nerve Fiber Layer

References
[1] Sarah Polack, David Yorston, Antonio Lopez-Ramos, Sergio Lepe-Orta, Rogerio Martins Baia, Luciano Alveset al. Rapid Assessment of Avoidable Blindness and Diabetic Retinopathy in Chiapas, Mexico. Ophthalmology. 2012; 119:1033-40.
[2] Gerald Liew, Michell Michaelides, Catey Bounce. A comparison of the causes of blindness certifications in England and Wales in working age adults (16–64 years), 1999–2000 with 2009–2010. BMJ open 2014; 4(2):1-6.
[3] World Health Organization. ICD-10 International Statistical Classification of Diseases and Related Health Problems. 10th revisión, 2nd ed. Vol. 2, Blindness and low visión. Geneva Switzerland; WHO; 2010. ISBN: 978 92 4 154834 2.
[4] Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology. 1981; 88(7):583-600.
[5] Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Archives of Ophthalmology. 1985; 103(12):1796-1806.
[6] Schlottmann P, Acosta C, Alezzandrini A. A, Befalluy J., Biccas L., Hidalgo Cano. Definición de estándares de buenas prácticas para el diagnóstico y tratamiento de la retinopatía diabética y el edema macular diabético en America Latina. The Pan-American Journal of Ophthalmology supplement. 2014; 13 suppl 1:24-27.
[7] Daniel F. Kiernan, Seenu M. Hariprasad. Normative Databases in SD-OCT: A Status Report. Normative Databases in SD-OCT: A Status Report: A comprehensive look at the evolution of OCT software design and database development. Fecha en que fue consultado: junio 20 de 2016.
[8] Theodossiadis GP, Boudouri A, Georgopoulos G. Central Visual Fields Changes after panretinal photocoagulation in proliferative diabetic retinopathy. Ophthalmologica 1990; 201(2):71-78.
[9] Alexander J. Brucker. An Observational Study of the Development of Diabetic Macular, Edema Following Panretinal (Scatter) Photocoagulation (PRP) Given in 1 or 4 Sittings. Arch Ophthalmol. 2009; 127(2):132-140.
[10] H. Richard McDonald, Howard Shatz. Vissual loss followiing panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology. 1985; 92(3):132-140.
[11] Einar Stefanson. The therapeutic effects of retinal laser treatment and vitrectomy. A theory base on oxygen and vascular physiology. Acta ophthalmol scand Suppl. 2001; 79:435-440.
[12] Katharina Kriechbaum, Matthias Bolz, Gabor G. Deak, Sonja Prager, Christopher Scholda, Ursula Schmidt-Erfurth. High resolution imaging of the human retina in vivo after scatter photocoagulation treatment using semiautomated laser system. Ophthalmology. 2010; 117(3); 545-551.
[13] Christoph Mitsch, Berthold Pemp, Katharina Kriechbaum, Matthias Bolz, Christoph Scholda, Ursula Schmidt-Erfurth. Retinal morphometry changes Measured with spectral Domain-optical coherence Tomography after pan-retinal Photocoagulation in patients With proliferative diabetic Retinopathy. Retina. 2016; 36(6); 1162-1169.
[14] Sung B. Lee, Joo Y. Kwag, Haeng J. Lee, Young J. Jo, Jung Y. Kim. The longitudinal changes of retinal nerve fiber layer thickness after panretinal Photocoagulation in diabetic retinopathy patients. Retina. 2013; 33:188-193.
[15] Michele C. Lim, Suzana A. Tanimoto, Bruno A. Furlani, Brent Lum, Luciano M. Pinto, David Eliason. Effect of Diabetic Retinopathy and Panretinal Photocoagulation on Retinal Nerve Fiber Layer and Optic Nerve Appearance. Arch Ophthalmol. 2009; 127(7); 857-862.
[16] Mahuil M. K. Muquit, Georger R. Marcelino, David B. Henson, Cecilia H. Fenerty, Paulo E. Stanga. Randomized clinical trial to evaluate the effects of pascal panretinal photocoagulation on macular nerve fiber layer, Manchester Pascal Study Report 3. Retina. 2011; 31(8):1669-1707.
[17] Faried M. Wagdy, Hoda M. El Sobky, Abd El-Rahman E. Sarhan, Mohammed A. Hafez. Evaluation of retinal nerve fiber layer thickness in diabetic retinopathy by optical coherence tomography after full scatter panretinal argon laser photocoagulation. J Egypt Ophthalmol Soc. 2013; 106:153-158.
[18] Hsu SY, Chung CP. Evaluation of retinal nerve fiber layer thickness in diabetic retinopathy after panretinal photocoagulation. Kaohsiung J Med Sci. 2002; 18(8):397-400.
[19] Michele C. Lim, Suzana A. Tanimoto, Bruno A. Purlani, Brent Lum, Luciano M Pinto, David Eliason, et al. Effect of Diabetic Retinopathy and Panretinal Photocoagulation on Retinal Nerve Fiber Layer and Optic Nerve Appearance. Arch ophthalmol. 2009; 127(7):851-862.
[20] Muqit MM, Sanghvi C, McLauchlan R, Delgado C, Young LB, Charles SJ, Marcellino GR, Stanga PE. Study of clinical applications and safety for Pascal® laser photocoagulation in retinal vascular disorders. Acta ophthalmol. 2012; 90(2):155-161.
[21] Yi-Ryeung Park, Donghyun Jee. Changes in Peripapillary Retinal Nerve Fiber Layer Thickness after Pattern Scanning Laser Photocoagulation in Patients with Diabetic Retinopathy. Korean J Ophthalmol. 2014; 28(3):220-225.
[22] Giacomo Savini, Piero Barboni, Michele Carbonelli, Alessandra Shreglia, Giulia Deluigi. Comparison of optic nerve head parameter measurement obtained by time-domain and Spectral-domain optical coherence tomography. Glaucoma, 2013; 22(5):385-389.
Author Information
  • Department of Ophthalmology, University of Guadalajara, Regional Hospital “Valentin Gomez Farias”, Jalisco, Mexico

Cite This Article
  • APA Style

    Manuel Eliezer Manzanero Hernandez. (2017). Changes in Peripapillar Retinal Nerve Fiber Layer Analized by Td-Oct in Patients with Diabetic Retinopathy That Receive Panretinal Photocoagulation. International Journal of Ophthalmology & Visual Science, 3(1), 1-6. https://doi.org/10.11648/j.ijovs.20180301.11

    Copy | Download

    ACS Style

    Manuel Eliezer Manzanero Hernandez. Changes in Peripapillar Retinal Nerve Fiber Layer Analized by Td-Oct in Patients with Diabetic Retinopathy That Receive Panretinal Photocoagulation. Int. J. Ophthalmol. Vis. Sci. 2017, 3(1), 1-6. doi: 10.11648/j.ijovs.20180301.11

    Copy | Download

    AMA Style

    Manuel Eliezer Manzanero Hernandez. Changes in Peripapillar Retinal Nerve Fiber Layer Analized by Td-Oct in Patients with Diabetic Retinopathy That Receive Panretinal Photocoagulation. Int J Ophthalmol Vis Sci. 2017;3(1):1-6. doi: 10.11648/j.ijovs.20180301.11

    Copy | Download

  • @article{10.11648/j.ijovs.20180301.11,
      author = {Manuel Eliezer Manzanero Hernandez},
      title = {Changes in Peripapillar Retinal Nerve Fiber Layer Analized by Td-Oct in Patients with Diabetic Retinopathy That Receive Panretinal Photocoagulation},
      journal = {International Journal of Ophthalmology & Visual Science},
      volume = {3},
      number = {1},
      pages = {1-6},
      doi = {10.11648/j.ijovs.20180301.11},
      url = {https://doi.org/10.11648/j.ijovs.20180301.11},
      eprint = {https://download.sciencepg.com/pdf/10.11648.j.ijovs.20180301.11},
      abstract = {In this study, changes in Retinal Nerve Fiber Layer (RNFL) within peripapillar zone in patients with diabetic retinopathy that accomplish criteria to receive panretinal photocoagulation are analyzed by TD-OCT (Time Domain-Optic Coherence Tomography) unit. This analysis was transversal retrospective and observational and was done in 46 eyes from 33 patients. According to laser application technique, time since application and day of the study, 4 groups of patients were set: the first with patients with less than 30 days since last laser application and day of study. The second with patients with 180 days since laser photocoagulation; the last two groups received panretinal photocoagulation plus macular selective laser with a TD-OCT performed 30 days (for the third group) and 180 days (the fourth group) after administration of treatment. The clinically significant finding was in comparing the group that received panretinal photocoagulation with TD-OCT after 30 days, and the group that received panretinal photocoagulation and TD-OCT after 180 days. Average thickness was less in the second group, with a statistical significant finding p=0.012 in inferior quadrant. Administer laser photocoagulation makes changes in the structure and function of the retina, and according to references many different results may be possible taking in count the equipment used to apply treatment and to take measurements. The patient must be informed about secondary and adverse effects after the treatment},
     year = {2017}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Changes in Peripapillar Retinal Nerve Fiber Layer Analized by Td-Oct in Patients with Diabetic Retinopathy That Receive Panretinal Photocoagulation
    AU  - Manuel Eliezer Manzanero Hernandez
    Y1  - 2017/12/05
    PY  - 2017
    N1  - https://doi.org/10.11648/j.ijovs.20180301.11
    DO  - 10.11648/j.ijovs.20180301.11
    T2  - International Journal of Ophthalmology & Visual Science
    JF  - International Journal of Ophthalmology & Visual Science
    JO  - International Journal of Ophthalmology & Visual Science
    SP  - 1
    EP  - 6
    PB  - Science Publishing Group
    SN  - 2637-3858
    UR  - https://doi.org/10.11648/j.ijovs.20180301.11
    AB  - In this study, changes in Retinal Nerve Fiber Layer (RNFL) within peripapillar zone in patients with diabetic retinopathy that accomplish criteria to receive panretinal photocoagulation are analyzed by TD-OCT (Time Domain-Optic Coherence Tomography) unit. This analysis was transversal retrospective and observational and was done in 46 eyes from 33 patients. According to laser application technique, time since application and day of the study, 4 groups of patients were set: the first with patients with less than 30 days since last laser application and day of study. The second with patients with 180 days since laser photocoagulation; the last two groups received panretinal photocoagulation plus macular selective laser with a TD-OCT performed 30 days (for the third group) and 180 days (the fourth group) after administration of treatment. The clinically significant finding was in comparing the group that received panretinal photocoagulation with TD-OCT after 30 days, and the group that received panretinal photocoagulation and TD-OCT after 180 days. Average thickness was less in the second group, with a statistical significant finding p=0.012 in inferior quadrant. Administer laser photocoagulation makes changes in the structure and function of the retina, and according to references many different results may be possible taking in count the equipment used to apply treatment and to take measurements. The patient must be informed about secondary and adverse effects after the treatment
    VL  - 3
    IS  - 1
    ER  - 

    Copy | Download

  • Sections